Giulia Anna Follacchio | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [99mTc]Tc-HMPAO-labelling procedure: a quality control study	NUCLEAR MEDICINE AND BIOLOGY	2021
Why SLNB procedure is not currently used in early stage oral squamous cell carcinoma?	ORAL ONCOLOGY	2020
Functional lung volume mapping with perfusion SPECT scan for radiotherapy planning in patients with locally advanced NSCLC	NUCLEAR MEDICINE COMMUNICATIONS	2020
Radium‑223 in patients with metastatic castration‑resistant prostate cancer: efficacy and safety in clinical practice	ONCOLOGY LETTERS	2019
Safety and Efficacy of Combined Peptide Receptor Radionuclide Therapy and Liver Selective Internal Radiation Therapy in a Patient With Metastatic Neuroendocrine Tumor	CLINICAL NUCLEAR MEDICINE	2019
Lymphoscintigraphy for the evaluation of limb lymphatic flow disorders: report of technical procedural standards from an Italian Nuclear Medicine expert panel [Linfogammagrafía para la evaluación de trastornos del flujo linfático de las extremidades: informe de estándares de procedimientos técnicos de un panel de expertos de medicina nuclear italiano]	REVISTA ESPAÑOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR	2019
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration‐resistant prostate cancer treated with 223Radium	EUROPEAN JOURNAL OF CANCER CARE	2019
Nuclear medicine procedures in neuroblastoma	Neuroblastoma	2019
In vivo imaging of infection with 99mTc-Labelled Human Beta-Defensin-3 in a Rat Model	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING	2019
HMGB1 expression in leukocytes as a marker of cellular stress induced by 99mTc-HMPAO-labelling procedure: a pilot study	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING	2019
In vivo microbial targeting of 99mTc-Labeled Human β-Defensin-3 in a rat model of infection	CLINICAL NUCLEAR MEDICINE	2019
223Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature	AGING CLINICAL AND EXPERIMENTAL RESEARCH	2018
A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with223Radium-dichloride	ANNALS OF NUCLEAR MEDICINE	2018
Radiopharmaceuticals labelled with copper radionuclides: clinical results in human beings	CURRENT RADIOPHARMACEUTICALS	2018
A challenging case of tumor-induced osteomalacia: pathophysiological and clinical implications	CALCIFIED TISSUE INTERNATIONAL	2018
Combined Peptide Radio-Receptor Therapy (PRRT) And Liver Selective Internal Radiation Therapy (SIRT) In Patients With Metastatic Neuroendocrine Tumors: Which Is The Best Sequence?	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING	2018
Functional lung volume mapping with perfusional 99mTc-MAA SPECT for radiotherapy planning in patients with locally advanced NSCLC	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING	2018
Long-term chronic suppressive antibiotic therapy (CSAT) in chronic joint infection evaluated by (99m)Tc-HMPAO radiolabeled leucocytes scintigraphy (LS)	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING	2018
Use of 99mTc-EDDA/HYNIC-TOC (Tektrotyd) for Radioguided Surgery of Gastroenteropancreatic Neuroendocrine Tumors: A Feasibility Study	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING	2018
Feasibility of radioguided surgical nodal staging with Tc- EDDA/HYNIC-TOC (Tektrotyd®) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs): a pilot study	the journal of nuclear medicineTHE JOURNAL OF NUCLEAR MEDICINE	2018

KET

Life-science technologies & biotechnologies

Keywords

nuclear medicine

molecular imaging

Molecular therapy